CS logo
small CS logo
Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria

Foggia, Italy
Hospital in Foggia
Viale Luigi Pinto, 1, 71122 Foggia FG

About Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
17
Total Rows: 1

Clinical Trials at Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria


During the past decade, Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111000011331100000000000000Started TrialsCompleted Trails201520162017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
2008-04-01
2016-02-01
Completed
150
Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
2009-02-09
2014-10-10
Completed
129
"AIDA" Protocol (LAP 0493)
1993-10-01
2020-12-01
Unknown status
1,068
De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients
2011-06-01
2020-12-01
Unknown status
60
Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia
2012-01-01
2018-07-10
Completed
515
Nilotinib in PH+, BCR-, ABL+ CML Patients
2012-01-01
2018-04-27
Completed
109
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
2012-09-11
2019-05-05
Terminated
144
Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease
2012-12-01
2017-03-27
Completed
21

Rows per page:

1–17 of 17

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGruppo Italiano MalattieEMatologichedell'Adulto: 17Gruppo Italiano MalattieEMatologichedell'Adulto: 17

Created with Highcharts 11.1.0Top CollaboratorsEuropean Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1

Clinical Trials Conditions at Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria


According to Clinical.Site data, the most researched conditions in "Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria" are "Acute Myeloid Leukemia" (4 trials), "Leukemia" (2 trials), "ALL Ph Positive" (1 trials), "AML" (1 trials) and "Adult" (1 trials). Many other conditions were trialed in "Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria" in a lesser frequency.

Clinical Trials Intervention Types at Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria


Most popular intervention types in "Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria" are "Drug" (9 trials), "Other" (6 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nilotinib" (2 trials), "Rituximab" (2 trials), "Bortezomib" (1 trials), "Chemotherapy" (1 trials) and "Ibrutinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria


The vast majority of trials in "Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria" are 17 trials for "All" genders.

Clinical Trials Status at Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria


Currently, there are NaN active trials in "Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Phase 3: 2Phase 3: 2Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Unknown status: 5Unknown status: 5Recruiting: 4Recruiting: 4Active, not recruiting: 2Active, not recruiting: 2Terminated: 1Terminated: 1